Diagnostic value of serum IGF-1 and IGFBP-3 in growth hormone deficiency: a systematic review with meta-analysis
Authors:
- 13 September 2014
- journal article
- review article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 174 (4) , 419-427
Abstract
Serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) are conventionally considered available for the diagnosis of growth hormone deficiency (GHD), but the results about their diagnostic values are inconsistent among some recent epidemiological studies. The aim of this study is to assess the diagnostic values of serum IGF-1 and IGFBP-3 for GHD by conducting a systematic review and meta-analysis. Studies on serum IGF-1 and IGFBP-3 used in GHD diagnosis were systematically searched from databases PubMed, EMBASE, and CNKI (up to December 2013). Characteristics of the studies and data were independently collected according to the inclusion criteria by two authors. The quality of included studies was assessed using quality assessment of diagnostic accuracy studies (QUADAS). Both sensitivity (SEN) and specificity (SPE) of IGF-1 and IGFBP-3 in GHD diagnosis were estimated on statistical software Meta-DiSc and Stata. A total of 12 studies were included for the final analysis. IGF-1 had SEN of 0.66, SPE of 0.69, positive likelihood ratio (PLR) of 2.48, negative likelihood ratio (NLR) of 0.51, area under the summary receiver operating characteristic curve (SROC) of 0.78, and Q* value of 0.72. Serum IGFBP-3 had SEN of 0.50, SPE of 0.79, PLR of 2.69, NLR of 0.64, area under SROC of 0.80, and Q* value of 0.73. Conclusion: Serum IGF-1 and IGFBP-3 are useful for the diagnosis of GHD and can be utilized as auxiliary diagnosis indexes for provocative test.Keywords
This publication has 33 references indexed in Scilit:
- Are IGF-I and IGF-BP3 Useful for Diagnosing Growth Hormone Deficiency in Children of Short Stature?Journal of Pediatric Endocrinology and Metabolism, 2010
- Multivariate random effects meta-analysis of diagnostic tests with multiple thresholdsBMC Medical Research Methodology, 2009
- Reevaluation of Growth Hormone Deficiency During and After Growth Hormone (GH) Treatment: Diagnostic Value of GH Tests and IGF-I and IGFBP-3 MeasurementsJournal of Pediatric Endocrinology and Metabolism, 2004
- Height velocity and IGF‐I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?Clinical Endocrinology, 2002
- Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiencyArchives of Disease in Childhood, 1999
- Plasma Levels of Insulin-Like Growth Factor (IGF)-I, IGF-II and IGF-Binding Protein-3 in the Evaluation of Childhood Growth Hormone DeficiencyHormone Research in Paediatrics, 1998
- Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3The Journal of Pediatrics, 1997
- Biochemical Diagnostic Strategies in the Evaluation of Short Stature: The Diagnosis of Insulin-Like Growth Factor DeficiencyHormone Research, 1996
- Plasma IGFBP‐3 and its relationship with quantitative growth hormone secretion in short children*Clinical Endocrinology, 1993
- The use of a commercially available somatomedin-C radioimmunoassay in patients with disorders of growthThe Journal of Pediatrics, 1981